David Meline - Seasoned Financial Executive Driving Growth and Transformation
Professional Overview
David Meline is an accomplished Chief Financial Officer with over 25 years of experience leading financial operations and strategy for global organizations. As the current CFO of Moderna, he leverages his deep expertise in the biotechnology and pharmaceutical industries to drive financial performance and support the company's mission of developing innovative mRNA therapeutics and vaccines.
Experience Summary
Current Role
David Meline has served as the Chief Financial Officer of Moderna since June 2020. In this role, he is responsible for overseeing the company's financial strategy, planning, and reporting, as well as leading the finance, accounting, tax, and treasury functions. Under his financial leadership, Moderna has achieved remarkable growth and successfully navigated the challenges of the COVID-19 pandemic, playing a pivotal role in the development and production of the Moderna COVID-19 vaccine.
Career Progression
Prior to joining Moderna, Meline held the CFO position at Amgen from 2014 to 2020, where he contributed to the company's successful expansion into new therapeutic areas and global markets. He also served as the CFO of 3M from 2008 to 2014, during which time he played a crucial role in driving operational efficiency and optimizing the company's financial structure. Earlier in his career, Meline held the role of Vice President of Finance at General Motors.
Academic Background
Meline holds a Bachelor of Science degree in Accounting from the University of Illinois at Urbana-Champaign. He is a certified public accountant and has also completed executive education programs at leading institutions such as Harvard Business School.
Areas of Expertise
- Financial strategy and planning
- Operational and capital efficiency
- Corporate finance and treasury management
- Mergers, acquisitions, and integration
- Financial reporting and internal controls
- Talent development and team building
Professional Impact
Throughout his career, Meline has demonstrated a strong track record of driving financial performance and supporting the strategic objectives of the organizations he has served. His strategic vision, financial acumen, and collaborative leadership style have been instrumental in guiding companies through periods of growth, transformation, and regulatory changes.
Conclusion
David Meline is a seasoned financial executive with a proven ability to navigate complex business environments and deliver sustainable value. As Moderna's CFO, he is well-positioned to leverage his extensive experience and industry expertise to support the company's continued success and impact in the biotechnology and pharmaceutical sectors.